You are here

Article Text

Article menu
Download PDFPDF
Review series
COPD exacerbations · 5: Management
  1. R Rodríguez-Roisin
  1. Correspondence to:
    Professor R Rodríguez-Roisin
    Servei de Pneumologia, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain; rororo{at}clinic.ub.es

Abstract

A review of the most relevant evidence based therapeutic options currently available for the management of exacerbations of COPD

  • COPD, chronic obstructive pulmonary disease
  • CRP, C-reactive protein
  • FEV1, forced expiratory volume in 1 second
  • LABA, long acting inhaled β2 agonist
  • LABD, long acting bronchodilator
  • MDI, metered dose inhaler
  • NIV, non-invasive ventilation
  • PEFR, peak expiratory flow rate
  • SABA, short acting β2 agonist
  • SABD, short acting bronchodilator
  • SAMA, short acting muscarinic antagonist
  • Sao2, arterial oxygen saturation
  • chronic obstructive pulmonary disease
  • exacerbations
  • management

https://doi.org/10.1136/thx.2005.041863

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text